Joseph Edelman – RYTM history
- Issuer:
- RHYTHM PHARMACEUTICALS INC
- Quarters tracked:
- 22 (Q4 2017 → Q1 2026)
- Current shares:
- 2,373,795
- Current value:
- $206.45M
- Peak shares:
- 3,680,473 (Q4 2024)
- Overall change:
- +219%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 2,373,795 | $206.45M | $86.97 | -172,596 | -7% |
| Q4 2025 | 2,546,391 | $272.57M | $107.04 | +107,422 | +4% |
| Q3 2025 | 2,438,969 | $288.39M | $118.24 | +20,670 | +1% |
| Q2 2025 | 2,418,299 | $152.81M | $63.19 | -130,146 | -5% |
| Q1 2025 | 2,548,445 | $134.99M | $52.97 | -1,132,028 | -31% |
| Q4 2024 | 3,680,473 | $206.03M | $55.98 | +120,259 | +3% |
| Q3 2024 | 3,560,214 | $186.52M | $52.39 | +113,635 | +3% |
| Q2 2024 | 3,446,579 | $141.52M | $41.06 | +178,000 | +5% |
| Q1 2024 | 3,268,579 | $141.63M | $43.33 | +1,114,469 | +52% |
| Q4 2023 | 2,154,110 | $99.02M | $45.97 | +1,773,282 | +466% |
| Q3 2023 | 380,828 | $8.73M | $22.92 | +380,828 | +100% |
| Q2 2020 | SOLD | — | — | -170,859 | -100% |
| Q1 2020 | 170,859 | $2.60M | $15.22 | 0 | 0% |
| Q4 2019 | 170,859 | $3.92M | $22.95 | +170,859 | +100% |
| Q3 2019 | SOLD | — | — | -262,970 | -100% |
| Q2 2019 | 262,970 | $5.79M | $22.00 | -240,000 | -48% |
| Q1 2019 | 502,970 | $13.79M | $27.41 | -6,216 | -1% |
| Q4 2018 | 509,186 | $13.76M | $27.03 | -155,000 | -23% |
| Q3 2018 | 664,186 | $19.37M | $29.17 | -136,500 | -17% |
| Q2 2018 | 800,686 | $25.03M | $31.26 | +208,400 | +35% |
| Q1 2018 | 592,286 | $11.79M | $19.90 | -152,849 | -21% |
| Q4 2017 | 745,135 | $21.65M | $29.06 | — | NEW |